Google to close Project Tango with the succession of ARCore

By Pouyan Broukhim
Share

Google has announced that it will be shutting down Project Tango, its augmented reality (AR) arm, come 1 March 2018, with Tango set to be succeeded by Google’s emerging ARCore unit.

Since the introduction of Project Tango in 2014, Google’s competitors have managed to bring AR features to their phones using just the handset’s onboard graphics, such as Apple with its ARKit, making their own AR technology much more accessible than Project Tango’s.

See also:

In order to compete, Google introduced ARCore in August – a new augmented reality system that would be able to offer the similar technology within the company’s Google Pixel handset range.

In this sense, the shutdown of Project Tango is of little surprise, with the company having made the announcement over Twitter.

“We’re turning down support for Tango on March 1, 2018,” the announcement read. “Thank you to our incredible community of developers who made such progress with Tango over the last three years. We look forward to continuing the journey with you on ARCore.”

In aim of expanding its presence within the AR market, Google is already offering its ARCore technology to Samsung’s Galaxy S8, with the aim of bringing it to numerous other phones in the future.

Share

Featured Articles

What is Nestlé CEO Laurent Freixe’s Action Plan?

Newly appointed CEO sets out action plan involving separating water brands into standalone business and boosting advertising and marketing spend

Will Mulberry Turn a New Leaf Under CEO Andrea Baldo?

International British luxury brand cuts quarter of head office staff as newly appointed CEO conducts strategic review

Female Board Members of Biggest UK Companies Paid 69% Less

Female board members of FTSE 100 companies are paid 69% less than male counterparts, as they find themselves frozen out of the biggest roles

Is This the Next CEO of LVMH?

Leadership & Strategy

How Burberry’s New CEO Is Going Back to Basics

Leadership & Strategy

Is Bayer CEO Bill Anderson Running Out of Time?

Leadership & Strategy